Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Median Sales Estimate At $7.1


The EPS projection of Five Prime Therapeutics, Inc. (NASDAQ:FPRX) for quarter ended 2016-09-30 is $-0.78. Last week, the EPS forecast was $-0.78 against target of $-0.78, a month earlier. Two months ago, this estimate was $-0.78 versus forecast of $-0.78 three months earlier, implying a deviation of 0%.

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) stated that 18 days ago, its stock price was positively revised 1 times while negative revisions were 2.

In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 1, 1, and 1, correspondingly.

EPS estimate downgrade for Five Prime Therapeutics, Inc. (NASDAQ:FPRX) in the preceding 30, 120, 60 and 90 days were 0, 2, 2, and 2, correspondingly.

Earnings Surprises

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) EPS target for the quarter closed 1 was $-0.78, based on 4 recommendations. As reported on 2016-05-05 the EPS was $-0.49. The change was $0.14, implying a percentage deviation of 22.22%. The projections showed a standard deviation of 0.36.

Quarterly Sales Estimates

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) yearly sales prediction for the fiscal 2016 stands at $8.743 and the median estimate is at $7.1. Almost 3 analysts issued sales target.

Highest sales target is $15 while the lowest target is $4.13 showing standard deviation of 5.618%.

As many as 3 analysts have sales targets revised upside while 3 reduced sales estimates, implying a deviation of 0%.

Last month, 3 revised sales number projection on upside while 3 lowered the sales projections, implying a deviation of 0%.

A quarter ago, 3 hiked sales target and 3 reduced sales forecast. Five Prime Therapeutics, Inc. (NASDAQ:FPRX) announced that the deviation in forecast was -18.616%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 4 times, 1 visits today)